ACS Publications. Most Trusted. Most Cited. Most Read
Design and Synthesis of Inhibitors of the E3 Ligase SMAD Specific E3 Ubiquitin Protein Ligase 1 as a Treatment for Lung Remodeling in Pulmonary Arterial Hypertension
My Activity
    Article

    Design and Synthesis of Inhibitors of the E3 Ligase SMAD Specific E3 Ubiquitin Protein Ligase 1 as a Treatment for Lung Remodeling in Pulmonary Arterial Hypertension
    Click to copy article linkArticle link copied!

    • Duncan E. Shaw*
      Duncan E. Shaw
      Novartis Institutes of Biomedical Research (NIBR), 250 Massachusetts Avenue, Cambridge Massachusetts 01239, United States
      *Email: [email protected]
    • Nichola Smith
      Nichola Smith
      Novartis Institutes of Biomedical Research (NIBR), 250 Massachusetts Avenue, Cambridge Massachusetts 01239, United States
    • Rene Beerli
      Rene Beerli
      NIBR Basel Fabrikstrasse 2, 4056 Basel, Switzerland
      More by Rene Beerli
    • Simona Cotesta
      Simona Cotesta
      NIBR Basel Fabrikstrasse 2, 4056 Basel, Switzerland
    • Pier-Luca D’Alessandro
      Pier-Luca D’Alessandro
      NIBR Basel Fabrikstrasse 2, 4056 Basel, Switzerland
    • Anne-Marie Edwards
      Anne-Marie Edwards
      NIBR, Wimblehurst Road, Horsham West Sussex RH12 5AB, U.K.
    • Rene Lattmann
      Rene Lattmann
      NIBR Basel Fabrikstrasse 2, 4056 Basel, Switzerland
    • Dimitrios Lizos
      Dimitrios Lizos
      NIBR Basel Fabrikstrasse 2, 4056 Basel, Switzerland
    • Robert Pulz
      Robert Pulz
      NIBR Basel Fabrikstrasse 2, 4056 Basel, Switzerland
      More by Robert Pulz
    • Lisa Rooney
      Lisa Rooney
      NIBR, Wimblehurst Road, Horsham West Sussex RH12 5AB, U.K.
      More by Lisa Rooney
    • Bindi Sohal
      Bindi Sohal
      NIBR, Wimblehurst Road, Horsham West Sussex RH12 5AB, U.K.
      More by Bindi Sohal
    • Caroline Rynn
      Caroline Rynn
      NIBR Basel Fabrikstrasse 2, 4056 Basel, Switzerland
    • Jessica Taylor
      Jessica Taylor
      NIBR, Wimblehurst Road, Horsham West Sussex RH12 5AB, U.K.
    • Thomas Troxler
      Thomas Troxler
      NIBR Basel Fabrikstrasse 2, 4056 Basel, Switzerland
    • Gareth Williams
      Gareth Williams
      NIBR Basel Fabrikstrasse 2, 4056 Basel, Switzerland
    • Sabine Guth
      Sabine Guth
      NIBR Basel Fabrikstrasse 2, 4056 Basel, Switzerland
      More by Sabine Guth
    • David Rowlands
      David Rowlands
      Novartis Institutes of Biomedical Research (NIBR), 250 Massachusetts Avenue, Cambridge Massachusetts 01239, United States
    Other Access OptionsSupporting Information (2)

    Journal of Medicinal Chemistry

    Cite this: J. Med. Chem. 2023, 66, 12, 8130–8139
    Click to copy citationCitation copied!
    https://doi.org/10.1021/acs.jmedchem.3c00229
    Published June 9, 2023
    Copyright © 2023 American Chemical Society

    Abstract

    Click to copy section linkSection link copied!
    Abstract Image

    Pulmonary arterial hypertension (PAH) is a devastating rare disease, which despite currently available treatments, still represents a high unmet medical need. Specific E3 ubiquitin protein ligase 1 (SMURF1) is a HECT E3 ligase that ubiquitinates key signaling molecules from the TGFβ/BMP pathways, which are of great relevance in the pathophysiology of PAH. Herein, the design and synthesis of novel potent small-molecule SMURF1 ligase inhibitors are described. Lead molecule 38 has demonstrated good oral pharmacokinetics in rats and significant efficacy in a rodent model of pulmonary hypertension.

    Copyright © 2023 American Chemical Society

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. Add or change your institution or let them know you’d like them to include access.

    Supporting Information

    Click to copy section linkSection link copied!

    The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jmedchem.3c00229.

    • SMILES Strings for all compounds (CSV)

    • Characterization data for final compounds 1H NMR, and LCMS (PDF)

    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.

    Cited By

    Click to copy section linkSection link copied!
    Citation Statements
    Explore this article's citation statements on scite.ai

    This article is cited by 6 publications.

    1. Dongha Kim, Hye Jin Nam, Sung Hee Baek. Ubiquitination of transcription factors in cancer: unveiling therapeutic potential. Molecular Oncology 2025, 70 https://doi.org/10.1002/1878-0261.70033
    2. Alexander M.K. Rothman, Amir Florentin, Florence Zink, Catherine Quigley, Olivier Bonneau, Rene Hemmig, Amanda Hachey, Tomas Rejtar, Maulik Thaker, Rishi Jain, Shih-Min Huang, Daniel Sutton, Jan Roger, Ji-Hu Zhang, Sven Weiler, Simona Cotesta, Johannes Ottl, Salil Srivastava, Alina Kordonsky, Reut Avishid, Elon Yariv, Ritu Rathi, Oshrit Khvalevsky, Thomas Troxler, Sarah K. Binmahfooz, Oded Kleifeld, Nicholas W. Morrell, Marc Humbert, Matthew J. Thomas, Gabor Jarai, Rohan E.J. Beckwith, Jennifer S. Cobb, Nichola Smith, Nils Ostermann, John Tallarico, Duncan Shaw, Sabine Guth-Gundel, Gali Prag, David J. Rowlands. Therapeutic potential of allosteric HECT E3 ligase inhibition. Cell 2025, 19 https://doi.org/10.1016/j.cell.2025.03.001
    3. Li-Fang Liang, Jia-Qi Zhao, Yi-Fei Wu, Hui-Jie Chen, Tian Huang, Xiao-He Lu. SMAD specific E3 ubiquitin protein ligase 1 accelerates diabetic macular edema progression by WNT inhibitory factor 1. World Journal of Diabetes 2025, 16 (3) https://doi.org/10.4239/wjd.v16.i3.101328
    4. Lingling Chen, Jie Tang, Yunli Chang, Dongyun Hang, Jieru Ji, Guoyu Chen. SMURF1 leads to the β-catenin signaling-mediated progression of esophageal squamous carcinoma by losing PATZ1-induced CCNG2 transcription. Biochemical Pharmacology 2025, 232 , 116688. https://doi.org/10.1016/j.bcp.2024.116688
    5. Franca M. Cordero, Donatella Giomi, Fabrizio Machetti. Five-membered ring systems with O and N atoms. 2024, 275-308. https://doi.org/10.1016/B978-0-443-33494-8.00020-2
    6. Dong Wang, Yuanming Zou, Xinyue Huang, Zeyu Yin, Mohan Li, Jiaqi Xu, Boquan Wu, Da Li, Ying Zhang, Yingxian Sun, Xingang Zhang, Naijin Zhang. The role of SMURFs in non‐cancerous diseases. The FASEB Journal 2023, 37 (8) https://doi.org/10.1096/fj.202300598R

    Journal of Medicinal Chemistry

    Cite this: J. Med. Chem. 2023, 66, 12, 8130–8139
    Click to copy citationCitation copied!
    https://doi.org/10.1021/acs.jmedchem.3c00229
    Published June 9, 2023
    Copyright © 2023 American Chemical Society

    Article Views

    3084

    Altmetric

    -

    Citations

    Learn about these metrics

    Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

    Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.

    The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.